William Blair Has Bearish Estimate for USPH Q1 Earnings

U.S. Physical Therapy, Inc. (NYSE:USPH) – William Blair cut their Q1 2025 earnings per share (EPS) estimates for shares of U.S. Physical Therapy in a report issued on Thursday, February 27th. William Blair analyst J. Haase now expects that the company will post earnings of $0.56 per share for the quarter, down from their previous estimate of $0.59. William Blair has a “Market Perform” rating on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. William Blair also issued estimates for U.S. Physical Therapy’s Q1 2025 earnings at $0.56 EPS, Q2 2025 earnings at $0.79 EPS, Q2 2025 earnings at $0.79 EPS, Q4 2025 earnings at $0.78 EPS, Q4 2025 earnings at $0.78 EPS, FY2025 earnings at $2.96 EPS and FY2025 earnings at $2.96 EPS.

Several other research analysts have also recently weighed in on the company. StockNews.com cut U.S. Physical Therapy from a “hold” rating to a “sell” rating in a report on Friday. JPMorgan Chase & Co. boosted their target price on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, December 3rd. Barrington Research lowered their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a report on Friday. JMP Securities began coverage on U.S. Physical Therapy in a report on Monday, December 16th. They set an “outperform” rating and a $113.00 target price on the stock. Finally, Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. One research analyst has rated the stock with a sell rating, one has given a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $111.50.

U.S. Physical Therapy Trading Down 1.6 %

USPH stock opened at $81.08 on Friday. The stock has a market cap of $1.22 billion, a price-to-earnings ratio of 86.26, a PEG ratio of 3.54 and a beta of 1.48. The business’s 50-day moving average is $88.20 and its 200 day moving average is $87.60. U.S. Physical Therapy has a 12-month low of $76.18 and a 12-month high of $113.63. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The firm had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million.

Institutional Trading of U.S. Physical Therapy

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in U.S. Physical Therapy by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 1,084,197 shares of the company’s stock valued at $96,179,000 after purchasing an additional 6,393 shares during the period. Copeland Capital Management LLC raised its position in U.S. Physical Therapy by 9.5% in the fourth quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock valued at $74,459,000 after purchasing an additional 72,715 shares during the period. State Street Corp raised its position in U.S. Physical Therapy by 17.5% in the third quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after purchasing an additional 99,244 shares during the period. Southernsun Asset Management LLC raised its position in U.S. Physical Therapy by 4.5% in the fourth quarter. Southernsun Asset Management LLC now owns 571,809 shares of the company’s stock valued at $50,725,000 after purchasing an additional 24,698 shares during the period. Finally, Dimensional Fund Advisors LP raised its position in U.S. Physical Therapy by 1.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 426,298 shares of the company’s stock valued at $37,818,000 after purchasing an additional 7,890 shares during the period.

Insider Activity

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the business’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $96.25, for a total value of $49,665.00. Following the sale, the chief financial officer now owns 20,469 shares of the company’s stock, valued at $1,970,141.25. The trade was a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be given a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a dividend yield of 2.22%. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy’s payout ratio is presently 95.65%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.